207 related articles for article (PubMed ID: 16059654)
1. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells.
Sarissky M; Lavicka J; Kocanová S; Sulla I; Mirossay A; Miskovsky P; Gajdos M; Mojzis J; Mirossay L
Neoplasma; 2005; 52(4):352-9. PubMed ID: 16059654
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic activity of hypericin in human urinary bladder carcinoma cells.
Kamuhabwa AR; Agostinis P; D'Hallewin MA; Kasran A; de Witte PA
Anticancer Res; 2000; 20(4):2579-84. PubMed ID: 10953329
[TBL] [Abstract][Full Text] [Related]
3. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
[TBL] [Abstract][Full Text] [Related]
4. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines.
Stupáková V; Varinská L; Mirossay A; Sarisský M; Mojzis J; Dankovcík R; Urdzík P; Ostró A; Mirossay L
Phytother Res; 2009 Jun; 23(6):827-32. PubMed ID: 19173218
[TBL] [Abstract][Full Text] [Related]
6. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines.
Ritz R; Wein HT; Dietz K; Schenk M; Roser F; Tatagiba M; Strauss WS
Int J Oncol; 2007 Mar; 30(3):659-67. PubMed ID: 17273767
[TBL] [Abstract][Full Text] [Related]
8. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria.
Miccoli L; Beurdeley-Thomas A; De Pinieux G; Sureau F; Oudard S; Dutrillaux B; Poupon MF
Cancer Res; 1998 Dec; 58(24):5777-86. PubMed ID: 9865736
[TBL] [Abstract][Full Text] [Related]
9. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
Ali SM; Olivo M
Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro.
Zhang W; Anker L; Law RE; Hinton DR; Gopalakrishna R; Pu Q; Gundimeda U; Weiss MH; Couldwell WT
Clin Cancer Res; 1996 May; 2(5):843-6. PubMed ID: 9816239
[TBL] [Abstract][Full Text] [Related]
11. p53 Status does not affect photodynamic cell killing induced by hypericin.
Lee HB; Ho AS; Teo SH
Cancer Chemother Pharmacol; 2006 Jul; 58(1):91-8. PubMed ID: 16211395
[TBL] [Abstract][Full Text] [Related]
12. A comparative study on the photocytotoxicity of hypericin on A431 cells using three different assays.
Ugwu F; Vandenbogaerde AL; Merlevede WJ; de Witte PA
Anticancer Res; 1998; 18(2A):1181-4. PubMed ID: 9615785
[TBL] [Abstract][Full Text] [Related]
13. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
15. Hypericin-mediated photocytotoxic effect on HT-29 adenocarcinoma cells is reduced by light fractionation with longer dark pause between two unequal light doses.
Sacková V; Kuliková L; Mikes J; Kleban J; Fedorocko P
Photochem Photobiol; 2005; 81(6):1411-6. PubMed ID: 16354114
[TBL] [Abstract][Full Text] [Related]
16. Hypericin-an inhibitor of proteasome function.
Pajonk F; Scholber J; Fiebich B
Cancer Chemother Pharmacol; 2005 May; 55(5):439-46. PubMed ID: 15672261
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
[TBL] [Abstract][Full Text] [Related]
18. The multifaceted photocytotoxic profile of hypericin.
Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
[TBL] [Abstract][Full Text] [Related]
19. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
Du HY; Li Y; Olivo M; Yip GW; Bay BH
Oncol Rep; 2006 Dec; 16(6):1397-402. PubMed ID: 17089067
[TBL] [Abstract][Full Text] [Related]
20. Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders.
Fox FE; Niu Z; Tobia A; Rook AH
J Invest Dermatol; 1998 Aug; 111(2):327-32. PubMed ID: 9699738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
